A phase II trial of gemcitabine plus carboplatin in advanced transitional cell carcinoma of the urothelium

被引：0
|
作者：
Nong Xu
Xiao Chen Zhang
Jian Ping Xiong
Wei Jia Fang
Lan Fang Yu
Jiong Qian
Ling Zhang
机构：
[1] Zhejiang University,Department of Medical Oncology, The First Affiliated Hospital, School of Medicine
[2] Nanchang University,Department of Oncology, The First Affiliated Hospital
来源：
BMC Cancer | / 7卷
关键词：
Bone Metastasis; Carboplatin; Transitional Cell Carcinoma; Overall Response Rate; Eastern Cooperative Oncology Group Performance Status;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Gemcitabine in the treatment of patients with advanced transitional cell carcinoma: A phase II study
    Kuzel, T
    Stadler, W
    Raghavan, D
    Levine, E
    Vogelzang, N
    Roth, B
    Dorr, FA
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 1152 - 1152
  • [32] A phase II study of gemcitabine and oxaliplatin in advanced transitional cell carcinoma of the bladder
    Eroglu, Zeynep
    Fruehauf, John P.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 72 (01) : 263 - 267
  • [33] A phase II study of gemcitabine and oxaliplatin in advanced transitional cell carcinoma of the bladder
    Zeynep Eroglu
    John P. Fruehauf
    Cancer Chemotherapy and Pharmacology, 2013, 72 : 263 - 267
  • [34] A carboplatin-based regimen for the treatment of patients with advanced transitional cell carcinoma of the urothelium
    Small, EJ
    Fippin, LJ
    Ernest, ML
    Carroll, PR
    CANCER, 1996, 78 (08) : 1775 - 1780
  • [35] Phase II trial of gemcitabine and docetaxel in patients with advanced carcinoma of the urothelium - A trial of the eastern cooperative oncology group
    Dreicer, R
    Manola, J
    Schneider, DJ
    Schwerkoske, JF
    George, CS
    Roth, BJ
    Wilding, G
    CANCER, 2003, 97 (11) : 2743 - 2747
  • [36] Preliminary results of a phase II study of gemcitabine (G) plus cisplatin (C) in advanced or metastatic transitional cell carcinoma of the urothelium in a 21-day regimen.
    Lippert, CM
    Koser, M
    Wechsel, H
    Ehlert, C
    Mueller, D
    ANNALS OF ONCOLOGY, 2000, 11 : 79 - 79
  • [37] Weekly paclitaxel (P) plus carboplatin (C) as salvage therapy in metastatic transitional cell carcinoma (TCC) of the urothelium previously treated with MVAC: Phase II trial.
    Kouno, T
    Ando, M
    Yonemori, K
    Matsumoto, K
    Shimizu, C
    Komiyama, M
    Okajima, E
    Matsuoka, N
    Fujimoto, H
    Fujiwara, Y
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 432S - 432S
  • [38] Chemotherapy with gemcitabine, paclitaxel, and cisplatin in the treatment of patients with advanced transitional cell carcinoma of the urothelium
    Ecke, Thorsten H.
    Bartel, Peter
    Koch, Stefan
    Ruttloff, Juergen
    Theissig, Franz
    ONCOLOGY REPORTS, 2006, 16 (06) : 1381 - 1388
  • [39] Carboplatin and gemcitabine in metastatic transitional cell carcinoma of the urothelium: Effective treatment of patients with poor prognostic features
    Shannon, C
    Crombie, C
    Brooks, A
    Lau, H
    Drummond, M
    Gurney, H
    ANNALS OF ONCOLOGY, 2001, 12 (07) : 947 - 952
  • [40] Tislelizumab plus cisplatin/carboplatin and gemcitabine versus placebo plus cisplatin/carboplatin and gemcitabine in Chinese patients with advanced urothelial carcinoma: A phase III trial in progress
    Bi, Feng
    Li, Han-Zhong
    Zhu, Shaoxing
    Zou, Qing
    Tang, Jia
    Zhang, Wei
    Ye, Dingwei
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
12345